FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

Highlights: FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS Platform Trial Next steps include obtaining single...

ORGE CO LTD Accelerates Global Expansion With Full-Scale Entry Into Chinese Market

ORGE CO LTD Accelerates Global Expansion With Full-Scale Entry Into Chinese Market

SEOUL, South Korea, Dec. 10, 2025 /PRNewswire/ -- Korean organic food brand ORGE CO LTD is ramping up its global footprint as it moves forward with a full-scale entry into the Chinese market. The company recently held discussions with platform...

menu
menu